Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Money, benefits and housing news


From To
PrEP reduces HIV infections by over 95% in US ‘real world’ study

A study of people prescribed pre-exposure prophylaxis (PrEP) over a four-year period at a large centre in Los Angeles has found that HIV incidence in people

18 June 2019
Gus Cairns
US: Planning for Retirement While Living With HIV

Whether you're on public assistance or you're more well off, there are things you can do to plan for a secure future.

03 June 2019
The Body
People living with HIV forced to explain how they got it for insurance

Insurance companies are still probing people living with HIV to explain how they contracted it on application forms. Many are being put off taking out insurance because they find it distressing answering such an invasive and ‘unnecessary’ question.

23 May 2019
Rapid rehousing support for homeless people living with HIV improves housing and HIV outcomes

Homeless people with HIV who are provided with rapid rehousing and intensive, tailored case management are placed in stable housing more quickly and are twice as likely to

17 May 2019
Michael Carter
Older black HIV-positive women have more mental distress than other women with HIV, but get less help for it

A study looking at women aged over 45 living with HIV in the UK has found that while black African and Caribbean women experience greater social isolation

17 April 2019
Gus Cairns
Charity profited from dying HIV patients via punishing equity deals

The Macfarlane Trust was set up in 1988 by the Government to help patients with haemophilia who had been infected with HIV from contaminated blood. The charity handed out monthly payments and emergency grants using cash from the Department of Health. But it has emerged the MFT was also entering into equity deals with desperate victims at risk of losing their homes.

31 March 2019
Mirror Online
Non-adherence to HIV treatment for cost-saving reasons reported by 8% in American study

Much of the excessive cost of prescription drugs in the United States falls on patients, and national surveillance data has now found that this has a

27 March 2019
Roger Pebody
Up to 95% virologic response rate with rapid ART in safety-net clinic

Up to 95% of people with newly diagnosed HIV and beginning antiretroviral therapy (ART) within a week of diagnosis reached a viral load below 50 copies in the first year of therapy. High proportions of people in this San Francisco safety-net clinic had a substance use disorder, a major mental health diagnosis, or unstable housing.

14 March 2019
To end the HIV epidemic, addressing poverty and inequities one of most important treatments

What we need most urgently today is a new generation of rigorously evaluated, cost-effective HIV interventions focused on the fundamental contextual factors for disease. These factors include access to adequate housing , access to quality health care and health insurance , access to child care , education, employment status, gender equality and income.

16 February 2019
The Conversation
Uganda: Financial incentives do not boost HIV viral suppression rate

Financial incentives had no effect on viral suppression among HIV-positive adults in Uganda, according to a recent study. Researchers said these findings suggest a need for better interventions to promote the achievement of viral suppression.

25 January 2019
← First12345...20Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.